Bath & Body Works Investors Class Action Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy BBWI?
Source: Globenewswire
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per diluted share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting increasing pressure in a competitive market.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, opting to exit certain adjacencies and refocus on core categories to improve performance and restore growth potential.
- Legal Action: Investors have filed a class action lawsuit alleging that the company made misleading statements throughout the class period, failing to disclose adverse information, which could lead to significant losses for investors, with a deadline to file by March 16, 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 24.380
Low
15.00
Averages
20.14
High
26.00
Current: 24.380
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bath & Body Works Investors Class Action Reminder
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per diluted share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting increasing pressure in a competitive market.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, opting to exit certain adjacencies and refocus on core categories to improve performance and restore growth potential.
- Legal Action: Investors have filed a class action lawsuit alleging that the company made misleading statements throughout the class period, failing to disclose adverse information, which could lead to significant losses for investors, with a deadline to file by March 16, 2026.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, seeking to recover damages for affected parties.
- False Statement Allegations: The complaint alleges that executives made materially false and misleading statements during this period, failing to disclose significant adverse facts about the company's business, operations, and prospects, which misled investors regarding its financial health.
- Strategic Failures: The lawsuit highlights that the company's strategy of pursuing 'adjacencies, collaborations, and promotions' did not effectively grow the customer base, and reliance on brand collaborations to mask weak financial results exacerbated the risk of investor losses.
- Investor Action Recommendations: Affected investors are encouraged to apply to be lead plaintiffs by March 13, 2026, and the law firm offers its services on a contingency fee basis, reducing the financial burden on investors seeking justice.
See More
Faruqi & Faruqi Encourages Bath & Body Works Investors to Reach Out
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating potential claims against Bath & Body Works, particularly for investors who purchased securities between June 4, 2024, and November 19, 2025, indicating possible legal risks for the company.
- Investor Rights Reminder: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff, urging investors to act before this date to protect their legal rights.
- Contact Information Provided: Securities Litigation Partner Josh Wilson has provided direct contact numbers, encouraging affected investors to call 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options, demonstrating a commitment to client support.
- Class Action Context: This investigation is related to a federal securities class action already filed against Bath & Body Works, highlighting the legal challenges the company may face that could impact shareholder interests.
See More
Class Action Reminder for Bath & Body Works and BellRing Brands Investors
- Bath & Body Works Lawsuit: The company reported a 1% year-over-year revenue decline in Q3 2025, missing its growth guidance of 1-3%, with net income dropping 26% to $77 million, leading to a reduction in full-year sales guidance, indicating that its strategy of 'adjacencies, collaborations, and promotions' failed to effectively grow its customer base and reflects underlying financial weaknesses.
- Stock Price Plunge Impact: On November 20, 2025, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, severely undermining investor confidence in the company's future and highlighting market concerns regarding its financial health.
- BellRing Brands Lawsuit: BellRing Brands narrowed its fiscal 2025 net sales outlook to between $2.28 billion and $2.32 billion as of August 4, 2025, revealing that customer inventory accumulation was a safeguard against previous product shortages, which led to reduced new orders and significant competitive pressures weakening demand.
- Significant Stock Decline: Following the disappointing sales outlook, BellRing's stock price dropped by $17.46, nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025, leaving investors disheartened about the company's sales prospects and exacerbating market anxiety.
See More
Multiple Companies Facing Class Action Lawsuits
- Varonis Systems Lawsuit: Varonis Systems, Inc. (NASDAQ:VRNS) is facing allegations for failing to sustain its ARR growth from February 4 to October 28, 2025, which has severely undermined investor confidence and is expected to negatively impact its stock performance.
- Ardent Health Issues: Ardent Health, Inc. (NYSE:ARDT) is accused of inaccurately assessing the collectability of accounts receivable from July 18, 2024, to November 12, 2025, potentially distorting financial reports and affecting investor perceptions of its financial health.
- CoreWeave Risks: CoreWeave, Inc. (NASDAQ:CRWV) is alleged to have overstated its ability to meet customer demand from March 28 to December 15, 2025, which could lead to significant negative impacts on revenue, prompting investors to be cautious about its future performance.
- Bath & Body Works Challenges: Bath & Body Works, Inc. (NYSE:BBWI) is facing accusations of failing to meet financial guidance from June 4, 2024, to November 19, 2025, indicating serious flaws in its market strategy that could affect brand reputation and market share.
See More
Amazon Surpasses Walmart in Quarterly Revenue for the First Time
- Retail Market Shift: Amazon has surpassed Walmart in quarterly revenue for the first time, reporting $187.8 billion in sales for Q4 compared to Walmart's $180.5 billion, marking a significant shift in the retail landscape that could impact future market share distribution.
- Economic Data Release: The U.S. personal consumption expenditures price index for December will be released at 8:30 a.m. ET, serving as the Federal Reserve's preferred inflation gauge, alongside GDP, consumer spending, and income data, providing crucial insights into economic health for investors.
- Job Market Changes: Data shows the wage growth gap between job switchers and stayers has narrowed to 2 percentage points, down from 8.4 points in April 2022, reflecting the changing economic environment's impact on salary increases, particularly in hospitality and leisure sectors where staying is more beneficial for pay raises.
- California Housing Crisis: Due to skyrocketing rents and a housing shortage, the percentage of homeless individuals living in RVs in Santa Clara County has risen from 18% in 2019 to 37% last year, highlighting the severity of the housing crisis, prompting the government to allocate 128 RV spaces to assist residents in transition.
See More
Bath & Body Works Investors Class Action Reminder
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per diluted share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting increasing pressure in a competitive market.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, opting to exit certain adjacencies and refocus on core categories to improve performance and restore growth potential.
- Legal Action: Investors have filed a class action lawsuit alleging that the company made misleading statements throughout the class period, failing to disclose adverse information, which could lead to significant losses for investors, with a deadline to file by March 16, 2026.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, seeking to recover damages for affected parties.
- False Statement Allegations: The complaint alleges that executives made materially false and misleading statements during this period, failing to disclose significant adverse facts about the company's business, operations, and prospects, which misled investors regarding its financial health.
- Strategic Failures: The lawsuit highlights that the company's strategy of pursuing 'adjacencies, collaborations, and promotions' did not effectively grow the customer base, and reliance on brand collaborations to mask weak financial results exacerbated the risk of investor losses.
- Investor Action Recommendations: Affected investors are encouraged to apply to be lead plaintiffs by March 13, 2026, and the law firm offers its services on a contingency fee basis, reducing the financial burden on investors seeking justice.
See More
Faruqi & Faruqi Encourages Bath & Body Works Investors to Reach Out
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating potential claims against Bath & Body Works, particularly for investors who purchased securities between June 4, 2024, and November 19, 2025, indicating possible legal risks for the company.
- Investor Rights Reminder: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff, urging investors to act before this date to protect their legal rights.
- Contact Information Provided: Securities Litigation Partner Josh Wilson has provided direct contact numbers, encouraging affected investors to call 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options, demonstrating a commitment to client support.
- Class Action Context: This investigation is related to a federal securities class action already filed against Bath & Body Works, highlighting the legal challenges the company may face that could impact shareholder interests.
See More
Class Action Reminder for Bath & Body Works and BellRing Brands Investors
- Bath & Body Works Lawsuit: The company reported a 1% year-over-year revenue decline in Q3 2025, missing its growth guidance of 1-3%, with net income dropping 26% to $77 million, leading to a reduction in full-year sales guidance, indicating that its strategy of 'adjacencies, collaborations, and promotions' failed to effectively grow its customer base and reflects underlying financial weaknesses.
- Stock Price Plunge Impact: On November 20, 2025, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, severely undermining investor confidence in the company's future and highlighting market concerns regarding its financial health.
- BellRing Brands Lawsuit: BellRing Brands narrowed its fiscal 2025 net sales outlook to between $2.28 billion and $2.32 billion as of August 4, 2025, revealing that customer inventory accumulation was a safeguard against previous product shortages, which led to reduced new orders and significant competitive pressures weakening demand.
- Significant Stock Decline: Following the disappointing sales outlook, BellRing's stock price dropped by $17.46, nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025, leaving investors disheartened about the company's sales prospects and exacerbating market anxiety.
See More
Multiple Companies Facing Class Action Lawsuits
- Varonis Systems Lawsuit: Varonis Systems, Inc. (NASDAQ:VRNS) is facing allegations for failing to sustain its ARR growth from February 4 to October 28, 2025, which has severely undermined investor confidence and is expected to negatively impact its stock performance.
- Ardent Health Issues: Ardent Health, Inc. (NYSE:ARDT) is accused of inaccurately assessing the collectability of accounts receivable from July 18, 2024, to November 12, 2025, potentially distorting financial reports and affecting investor perceptions of its financial health.
- CoreWeave Risks: CoreWeave, Inc. (NASDAQ:CRWV) is alleged to have overstated its ability to meet customer demand from March 28 to December 15, 2025, which could lead to significant negative impacts on revenue, prompting investors to be cautious about its future performance.
- Bath & Body Works Challenges: Bath & Body Works, Inc. (NYSE:BBWI) is facing accusations of failing to meet financial guidance from June 4, 2024, to November 19, 2025, indicating serious flaws in its market strategy that could affect brand reputation and market share.
See More
Amazon Surpasses Walmart in Quarterly Revenue for the First Time
- Retail Market Shift: Amazon has surpassed Walmart in quarterly revenue for the first time, reporting $187.8 billion in sales for Q4 compared to Walmart's $180.5 billion, marking a significant shift in the retail landscape that could impact future market share distribution.
- Economic Data Release: The U.S. personal consumption expenditures price index for December will be released at 8:30 a.m. ET, serving as the Federal Reserve's preferred inflation gauge, alongside GDP, consumer spending, and income data, providing crucial insights into economic health for investors.
- Job Market Changes: Data shows the wage growth gap between job switchers and stayers has narrowed to 2 percentage points, down from 8.4 points in April 2022, reflecting the changing economic environment's impact on salary increases, particularly in hospitality and leisure sectors where staying is more beneficial for pay raises.
- California Housing Crisis: Due to skyrocketing rents and a housing shortage, the percentage of homeless individuals living in RVs in Santa Clara County has risen from 18% in 2019 to 37% last year, highlighting the severity of the housing crisis, prompting the government to allocate 128 RV spaces to assist residents in transition.
See More
